Lens fluorescence in relation to glucose tolerance and genetic predisposition to type 2 diabetes mellitus in a population-based study

被引:6
|
作者
Koefoed Theil, Pernille
Kessel, Line
Hansen, Torben
Lund-Andersen, Henrik
Pedersen, Oluf
Larsen, Michael
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark
[2] Steno Diabet Ctr, Copenhagen, Denmark
关键词
glucose metabolism; lens fluorescence; screening; type 2 diabetes mellitus;
D O I
10.1080/02713680600850971
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The fluorescence of the lens has the characteristics of a life-long cumulative index of glycemia, and it is elevated in patients with diabetes in proportion to the duration of diabetes and the level of glycemia. Consequently, lens fluorometry should be capable of providing an estimate of prediagnostic disease duration when patients are diagnosed with type 2 diabetes. Among euglycemic subjects, first-degree relatives of patients with type 2 diabetes tend to have higher glycemia levels than subjects who are unrelated to diabetes patients. They should therefore also have the higher lens fluorescence values. Methods: The study comprised 218 Caucasian subjects in self-reported good health aged 30-88 years who were recruited from population-based studies to represent approximately equal proportions of different type 2 diabetes family history characteristics: no diabetic relative, first-degree offspring, second-degree offspring, not first-degree offspring but possibly second-degree offspring, or uncertain family history. Characterization of subjects included oral glucose tolerance testing and lens fluorometry. Results: Type 2 diabetes was diagnosed in 10 subjects (4.6% of the population) and impaired glucose tolerance in 12 subjects (5.5%). Regression analysis indicated a prediagnostic duration of type 2 diabetes of 2.7 years versus 0.1 years for impaired glucose tolerance. Neither group demonstrated significantly increased lens fluorescence compared with euglycemic subjects. Being a first-degree relative of a patient with type 2 diabetes was associated with higher lens fluorescence than having no relative with diabetes (p = 0.02). Conclusions: Population screening by fasting blood glucose measurement can advance the diagnosis and initiation of treatment of type 2 diabetes mellitus by nearly a decade, compared with previous studies of patients diagnosed in routine clinical practice. In addition to higher than normal glycemia, euglycemic subjects who are offspring of patients with type 2 diabetes also have both elevated lens fluorescence and elevated glycemia. Fasting blood glucose measurement remains the method of choice for type 2 diabetes screening.
引用
收藏
页码:733 / 738
页数:6
相关论文
共 50 条
  • [41] HOSPITALIZATION IN DIABETES-MELLITUS - A POPULATION-BASED STUDY
    BALLARD, DJ
    PALUMBO, PJ
    MELTON, LJ
    SINNOCK, P
    BENDER, A
    DIABETES, 1986, 35 : A135 - A135
  • [42] Diabetic retinopathy-clinical and molecular genetic insights from a type 2 diabetes mellitus population-based cohort study.
    Pinazo-Duran, Maria D.
    Zanon-Moreno, Vicente
    Maria Sanz-Gonzalez, Silvia
    Garcia-Medina, Jose J.
    Raga-Cervera, Jorge
    Lopez-Galvez, Maribel
    Arevalo, Jose Fernando
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [43] Type 2 diabetes mellitus contributes to cognitive decline in old age: A longitudinal population-based study
    Hassing, LB
    Grant, MD
    Hofer, SM
    Pedersen, NL
    Nilsson, SE
    Berg, S
    Mcclearn, G
    Johansson, B
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2004, 10 (04) : 599 - 607
  • [44] Risk of type 2 diabetes mellitus in patients with acute critical illness: a population-based cohort study
    Hsu, Chin-Wang
    Lin, Chin-Sheng
    Chen, Sy-Jou
    Lin, Shih-Hua
    Lin, Cheng-Li
    Kao, Chia-Hung
    INTENSIVE CARE MEDICINE, 2016, 42 (01) : 38 - 45
  • [45] Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus
    Takano, T
    Yamakawa, T
    Takahashi, M
    Kimura, M
    Okamura, A
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (02) : 95 - 100
  • [46] Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain
    Mata-Cases, Manel
    Casajuana, Marc
    Franch-Nadal, Josep
    Casellas, Aina
    Castell, Conxa
    Vinagre, Irene
    Mauricio, Didac
    Bolibar, Bonaventura
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (08): : 1001 - 1010
  • [47] Prediabetes, type 2 diabetes mellitus and risk of Parkinson's disease: A population-based cohort study
    Sanchez-Gomez, Almudena
    Diaz, Yesika
    Duarte-Salles, Talita
    Compta, Yaroslau
    Jose Marti, Maria
    PARKINSONISM & RELATED DISORDERS, 2021, 89 : 22 - 27
  • [48] Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK
    Alwafi, Hassan
    Wei, Li
    Naser, Abdallah Y.
    Mongkhon, Pajaree
    Tse, Gary
    Man, Kenneth K. C.
    Bell, J. Simon
    Ilomaki, Jenni
    Fang, Gang
    Wong, Ian C. K.
    BMJ OPEN, 2020, 10 (05):
  • [49] Association of Uterine Leiomyoma with Type 2 Diabetes Mellitus in Young Women: A Population-Based Cohort Study
    Sung, Ji-Hee
    Kim, Kyung-Soo
    Han, Kyungdo
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2024, 48 (06) : 1105 - 1113
  • [50] Validation of Seven Type 2 Diabetes Mellitus Risk Scores in a Population-Based Cohort: The CoLaus Study
    Kraege, Vanessa
    Fabecic, Janko
    Marques-Vidal, Pedro
    Waeber, Gerard
    Mean, Marie
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : E265 - E272